
Choisissez votre étiquette
affichée directement sur le flaconRapport de laboratoire
PDF- Testé
- Telmisartan 40mg × 100 Tabs
- Laboratoire
- Analiza Białek
- Date
- October 2026
- Résultat
- 39.80 mg per tablet (40 mg label)
- N° de commande
- Mot de passe
Testé de manière indépendante, vérifiable avec le mot de passe directement auprès du laboratoire.
Telmisartan
Medication
- Testé en laboratoire
- Expédié depuis l'Allemagne
Commande
- DHL avec suivi
- Emballage discret
En un coup d'œil
Telmisartan en chiffres
Les chiffres clés de notre lexique. Faites glisser le point le long de la courbe pour voir ce qui reste après une dose, par calcul.
Article complet du lexiqueHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~24 hours
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
Approximately24hours
- Class
- Angiotensin II receptor antagonistARB
- Use
- Blood pressure controlcardiovascular protection
- Sizes
- 40 to 80 mg2 sizes in the shop
What studies show
All 3 sources in the lexicon- PMC10409965
- Gomaz et al., Indian Journal of Medical Research, 2026
Meta-analysis: Telmisartan-based combinations for hypertension and dyslipidemia (opens in a new tab)
PMC12647966
Avis
Ce que disent les clients
Uniquement des commandes réelles qui contenaient Telmisartan.
Tous les avisConnaissances
Tout sur Telmisartan
Informations détaillées bientôt disponibles.
Is telmisartan approved?
Yes. ChEMBL lists telmisartan with phase 4 as the highest phase and first approval in 1998. ClinicalTrials.gov lists 349 trials with telmisartan, as of 26 October 2026.
What did ONTARGET show?
25,620 patients with vascular disease or high-risk diabetes received ramipril, telmisartan or both. After about 56 months the primary outcome was 16.5, 16.7 and 16.3 percent. Telmisartan was equivalent, the combination brought no benefit but more side effects.
And if an ACE inhibitor is not tolerated?
TRANSCEND tested this in 5,926 patients against placebo. The primary outcome was not significantly less common at 15.7 versus 17.0 percent. Cardiovascular death, heart attack or stroke occurred in 13.0 versus 14.8 percent, also not significant after correction.
Why less cough than with ACE inhibitors?
According to ChEMBL telmisartan blocks the AT1 receptor and not the enzyme ACE. In ONTARGET 1.1 percent had cough with telmisartan, 4.2 percent with ramipril. Angioedema occurred in 0.1 versus 0.3 percent.
What was measured in heart failure with weak kidneys?
In a small open trial with 107 patients kidney function worsened less often than with enalapril after 3 months (6.4 versus 22.9 percent). Hospital stays for heart failure were less common (34.1 versus 55.3 percent), there were 5 deaths in each group.
What do the trials on insulin and combinations show?
In 70 patients with diabetes and high blood pressure HOMA-IR fell to 1.79 after 12 weeks instead of 3.45 with other blood pressure drugs. A meta-analysis of 3 trials found stronger blood pressure lowering with amlodipine and better LDL values with rosuvastatin, tolerability was similar.
Produits associés
Produits similaires
Ivermectin
Médicaments · Estomac et foie Estomac et foie
1 taille
Fenbendazol
Médicaments · Estomac et foie Estomac et foie
1 taille
Prednisone
Médicaments · Estomac et foie Estomac et foie
1 taille
Modafinil
Médicaments · Cognition et sommeil Cognition et sommeil
5 tailles
Telmisartan